Page 206 - Read Online
P. 206

Tagliari et al. Vessel Plus 2020;4:16  I  http://dx.doi.org/10.20517/2574-1209.2020.05                                                 Page 11 of 12

                   tricuspid regurgitation. Ann Thorac Surg 2013;95:77-84.
               18.  Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, et al. Percutaneous transarterial aortic valve replacement in selected high-
                   risk patients with aortic stenosis. Circulation 2007;116:755-63.
               19.  Tzikas A, Piazza N, van Dalen BM, Schultz C, Geleijnse ML, et al. Changes in mitral regurgitation after transcatheter aortic valve
                   implantation. Catheter Cardiovasc Interv 2010;75:43-9.
               20.  Barbanti M, Webb JG, Hahn RT, Feldman T, Boone RH, et al. Impact of preoperative moderate/severe mitral regurgitation on 2-year
                   outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER)
                   Trial Cohort A. Circulation 2013;128:2776-84.
               21.  Toggweiler S, Boone RH, Rodes-Cabau J, Humphries KH, Lee M, et al. Transcatheter aortic valve replacement: outcomes of patients
                   with moderate or severe mitral regurgitation. J Am Coll Cardiol 2012;59:2068-74.
               22.  Nombela-Franco L, Eltchaninoff H, Zahn R, Testa L, Leon MB, et al. Clinical impact and evolution of mitral regurgitation following
                   transcatheter aortic valve replacement: a meta-analysis. Heart 2015;101:1395-405.
               23.  Bedogni F, Latib A, DeMarco F, Agnifili M, Oreglia J, et al. Interplay between mitral regurgitation and transcatheter aortic valve
                   replacement with the CoreValve Revalving System: a multicenter registry. Circulation 2013;128:2145-53.
               24.  Cortes C, Amat-Santos IJ, Nombela-Franco L, Munoz-Garcia AJ, Gutierrez-Ibanes E, et al. Mitral regurgitation after transcatheter aortic
                   valve replacement: prognosis, imaging predictors, and potential management. J Am Coll Cardiol Cardiovasc Interv 2016;9:1603-14.
               25.  Taramasso M, Maisano F, Nietlispach F. TAVI and concomitant procedures: from PCI to LAA closure. EuroIntervention 2015;11:W96-100.
               26.  Ruel M, Kapila V, Price J, Kulik A, Burwash IG, et al. Natural history and predictors of outcome in patients with concomitant functional
                   mitral regurgitation at the time of aortic valve replacement. Circulation 2006;114:I541-6.
               27.  Almasood A, Al Ahmari S, El-Shurafa H, Alotaibi M, Al Kasab S, et al. The change in mitral regurgitation severity after transcatheter
                   aortic valve implantation. J Saudi Heart Assoc 2015;27:10-7.
               28.  Stähli BE, Reinthaler M, Leistner DM, Landmesser U, Lauten A. Transcatheter aortic valve replacement and concomitant mitral
                   regurgitation. Front Cardiovasc Med 2018;5:74.
               29.  Ando T, Takagi H, Briasoulis A, Telila T, Slovut DP, et al. A systematic review of reported cases of combined transcatheter aortic and
                   mitral valve interventions. Catheter Cardiovasc Interv 2018;91:124-34.
               30.  Veronesi F, Corsi C, Sugeng L, Mor-Avi V, Caiani EG, et al. A study of functional anatomy of aortic-mitral valve coupling using 3D
                   matrix transesophageal echocardiography. Circ Cardiovasc Imaging 2009;2:24-31.
               31.  Stelzmueller ME, Zilberszac R, Heinrich N, Mora B, Laufer G, et al. Concomitant transapical transcatheter aortic valve implantation and
                   transapical mitral valve repair with neochord implantation. Innovations (Phila) 2019;14:564-8.
               32.  Guerrero M, Dvir D, Himbert D, Urena M, Eleid M, et al. Transcatheter mitral valve replacement in native mitral valve disease with
                   severe mitral annular calcification: Results from the first multicenter global registry. J Am Coll Cardiol Intv 2016;9:1361-71.
               33.  Fanari Z, Mahmaljy H, Nandish S, Goswami NJ. Simultaneous transcatheter transfemoral aortic and transseptal mitral valve replacement
                   using Edward SAPIEN S3. Catheter Cardiovasc Interv 2018;92:988-92.
               34.  Sannino A, Grayburn PA. Mitral regurgitation in patients with severe aortic stenosis: diagnosis and management. Heart 2018;104:16-22.
               35.  Katte F, Franz M, Jung C, Figulla HR, Leistner D, et al. Impact of concomitant mitral regurgitation on transvalvular gradient and
                   flow in severe aortic stenosis: a systematic ex vivo analysis of a subentity of low-flow low-gradient aortic stenosis. EuroIntervention
                   2018;13:1635-44.
               36.  Bruce CJ, Connolly HM. Right-sided valve disease deserves a little more respect. Circulation 2009;119:2726-34.
               37.  Kim HK, Kim YJ, Park JS, Kim KH, Kim KB, et al. Determinants of the severity of functional tricuspid regurgitation. Am J Cardiol
                   2006;98:236-42.
               38.  Wilbring M, Tugtekin SM, Ritzmann M, Arzt S, Schmidt T, et al. Transcatheter aortic valve implantation reduces grade of concomitant
                   mitral and tricuspid valve regurgitation and pulmonary hypertension. Eur J Cardiothorac Surg 2014;46:818-24.
               39.  Lindman BR, Maniar HS, Jaber WA, Lerakis S, Mack MJ, et al. Effect of tricuspid regurgitation and the right hear on survival after
                   transcatheter aortic valve replacement: insights from the Placement of Aortic Transcatheter Valves II inoperable cohort. Circ Cardiovasc
                   Interv 2015;8:pii: e002073.
               40.  Takagi H, Hari Y, Kawai N, Ando T; ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. Impact of concurrent
                   tricuspid regurgitation on mortality after transcatheter aortic-valve implantation. Catheter Cardiovasc Interv 2019;93:946-53.
               41.  Pavasini R, Ruggerini S, Grapsa J, Biscaglia S, Tumscitz C, et al. Role of the tricuspid regurgitation after mitraclip and transcatheter
                   aortic valve implantation: a systematic review and meta-analysis. Eur Heart J Cardiovasc Imaging 2018;19:654-9.
               42.  Barbanti M, Binder RK, Dvir D, Tan J, Freeman M, et al. Prevalence and impact of preoperative moderate/severe tricuspid regurgitation
                   on patients undergoing transcatheter aortic valve replacement. Cathet Cardiovasc Intervent 2015;85:677-84.
               43.  Reichart D, Schofer N, Deuschl F, Schaefer A, Blankenberg S, et al. Transcatheter tricuspid valve-in-ring and aortic valve-in-valve
                   implantation. Thorac Cardiovasc Surg Rep 2017;6:e29-31.
               44.  Sideris S, Drakopoulou M, Oikonomopoulos G, Gatzoulis K, Stavropoulos G, et al. Left ventricular pacing through coronary sinus is
                   feasible and safe for patients with prior tricuspid valve intervention. Pacing Clin Electrophysiol 2016;39:378-81.
               45.  Faurie B, Abdellaoui M, Wautot F, Staat P, Champagnac D, et al. Rapid pacing using the left ventricular guidewire: reviving an old
                   technique to simplify BAV and TAVI procedures. Catheter Cardiovasc Interv 2016;88:988-93.
               46.  Abdi S, Nazeri I, Mandegar MH, Geraiely B, Mortazavi SH. Single-session double valve replacement: TAVI + tricuspid valve-in-valve
                   procedures. J Card Surg 2019;34:518-21.
               47.  Kurra V, Schoenhagen P, Roselli EE, Kapadia SR, Tuzcu EM, et al. Prevalence of significant peripheral artery disease in patients
   201   202   203   204   205   206   207   208   209   210   211